Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Buchanan

Showing results (651-660 of 884) with videos related to

Pageof 89
Sort By:
American Heart Journal|February 9, 2018
Temporal trends in patient referral for Transcatheter aortic valve replacement and reasons for exclusion at a high-volume Center in the United StatesKyle D Buchanan, Toby Rogers, M Chadi Alraies, et al.
Carcinogenesis|February 10, 2011
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patientsJames B Rawson, Michael Manno, Miralem Mrkonjic, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gut|September 2, 2016
Lack of evidence for germline <i>RNF43</i> mutations in patients with serrated polyposis syndrome from a large multinational studyDaniel D Buchanan, Mark Clendenning, Li Zhuoer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 29, 2022
Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older IndividualsAndrew Bakshi, Yin Cao, Suzanne G Orchard, et al.
Epigenetics|June 21, 2022
Does genetic predisposition modify the effect of lifestyle-related factors on DNA methylation?Chenglong Yu, Allison M Hodge, Ee Ming Wong, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal CancerJoice Kuroiwa-Trzmielina, Fan Wang, Robert W Rapkins, et al.
Hereditary Cancer in Clinical Practice|January 24, 2025
Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequencesPål Møller, Aysel Ahadova, Matthias Kloor, et al.
Leukemia|March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemiaC Parrish, G B Scott, G Migneco, et al.
Pageof 89

Showing results (651-660 of 884) with videos related to

Sort By:
Pageof 89
American Heart Journal|February 9, 2018
Temporal trends in patient referral for Transcatheter aortic valve replacement and reasons for exclusion at a high-volume Center in the United StatesKyle D Buchanan, Toby Rogers, M Chadi Alraies, et al.
Carcinogenesis|February 10, 2011
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patientsJames B Rawson, Michael Manno, Miralem Mrkonjic, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gut|September 2, 2016
Lack of evidence for germline <i>RNF43</i> mutations in patients with serrated polyposis syndrome from a large multinational studyDaniel D Buchanan, Mark Clendenning, Li Zhuoer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 29, 2022
Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older IndividualsAndrew Bakshi, Yin Cao, Suzanne G Orchard, et al.
Epigenetics|June 21, 2022
Does genetic predisposition modify the effect of lifestyle-related factors on DNA methylation?Chenglong Yu, Allison M Hodge, Ee Ming Wong, et al.
Clinical Genetics|September 29, 2012
Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expressionM Clendenning, F A Macrae, M D Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal CancerJoice Kuroiwa-Trzmielina, Fan Wang, Robert W Rapkins, et al.
Hereditary Cancer in Clinical Practice|January 24, 2025
Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequencesPål Møller, Aysel Ahadova, Matthias Kloor, et al.
Leukemia|March 28, 2015
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemiaC Parrish, G B Scott, G Migneco, et al.
Pageof 89